chr19-47048491-C-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_017854.2(TMEM160):​c.124G>A​(p.Gly42Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000119 in 1,422,980 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000087 ( 0 hom. )

Consequence

TMEM160
NM_017854.2 missense

Scores

1
3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.410

Publications

0 publications found
Variant links:
Genes affected
TMEM160 (HGNC:26042): (transmembrane protein 160) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06399235).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TMEM160NM_017854.2 linkc.124G>A p.Gly42Ser missense_variant Exon 1 of 3 ENST00000253047.7 NP_060324.1 Q9NX00

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TMEM160ENST00000253047.7 linkc.124G>A p.Gly42Ser missense_variant Exon 1 of 3 1 NM_017854.2 ENSP00000253047.5 Q9NX00

Frequencies

GnomAD3 genomes
AF:
0.0000394
AC:
6
AN:
152164
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000310
AC:
1
AN:
32276
AF XY:
0.0000512
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000749
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000866
AC:
11
AN:
1270706
Hom.:
0
Cov.:
32
AF XY:
0.00000965
AC XY:
6
AN XY:
622050
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
24518
American (AMR)
AF:
0.00
AC:
0
AN:
15734
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18802
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29400
South Asian (SAS)
AF:
0.0000157
AC:
1
AN:
63596
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
30518
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3606
European-Non Finnish (NFE)
AF:
0.00000388
AC:
4
AN:
1032048
Other (OTH)
AF:
0.000114
AC:
6
AN:
52484
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000394
AC:
6
AN:
152274
Hom.:
0
Cov.:
32
AF XY:
0.0000134
AC XY:
1
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41578
American (AMR)
AF:
0.000261
AC:
4
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67996
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113
Asia WGS
AF:
0.00116
AC:
4
AN:
3472

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 07, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.124G>A (p.G42S) alteration is located in exon 1 (coding exon 1) of the TMEM160 gene. This alteration results from a G to A substitution at nucleotide position 124, causing the glycine (G) at amino acid position 42 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.50
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0090
T
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.26
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Benign
0.68
T
M_CAP
Uncertain
0.18
D
MetaRNN
Benign
0.064
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
N
PhyloP100
0.41
PrimateAI
Pathogenic
0.89
D
PROVEAN
Benign
-0.75
N
REVEL
Benign
0.061
Sift
Benign
0.035
D
Sift4G
Benign
0.067
T
Polyphen
0.0010
B
Vest4
0.15
MutPred
0.10
Gain of phosphorylation at G42 (P = 0.0063);
MVP
0.11
MPC
1.0
ClinPred
0.14
T
GERP RS
3.3
PromoterAI
-0.0096
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.094
gMVP
0.44
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs912627975; hg19: chr19-47551749; API